Andor Glaudemans
prof. dr.
I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Responsevaluatie bij posttransplantatielymfomen door middel van F-FDG-PET/CT en circulerend tumor-DNA (MRD-PTLD)
The accuracy of diagnostic Imaging techniques in patients with a suspected Fracture-related Infection (IFI) trial: study protocol for a prospective multicenter cohort study
Published in: BMJ Open
Access to document
10.1136/bmjopen-2018-027772
document
Introduction The optimal diagnostic imaging strategy for fracture-related infection (FRI) remains to be established. In this prospective study, the three commonly used advanced imaging techniques for diagnosing FRI will be compared. Primary endpoints are (1) determining the overall diagnostic performances of white blood cell (WBC) scintigraphy, fluorodeoxyglucose positron emission tomography (FDG-PET) and magnetic resonance imaging (MRI) in patients with suspected FRI and (2) establishing the most accurate imaging strategy for diagnosing FRI. Methods and analysis This study is a non-randomised, partially blinded, prospective cohort study involving two level...
G. A. M. Govaert, M. G. G. Hobbelink, I. H. F. Reininga, P. Bosch, T. C. Kwee, P. A. de Jong, P. C. Jutte, H. C. Vogely, R. A. J. O. Dierckx, L. P. H. Leenen, A. W. J. M. Glaudemans, F. F. A. IJpma
Comparison of Fluorine(18)-fluorodeoxyglucose and Gallium(68)-citrate PET/CT in patients with tuberculosis
Published in: Nuklearmedizin-Nuclear medicine
Access to document
10.1055/a-1000-6951
document
(18) F-FDG and (68) Ga-citrate PET/CT have both been shown to be useful in the management of tuberculosis (TB). We compared the abnormal PET findings of (18) F-FDG- and (68) Ga-citrate-PET/CT in patients with TB. Methods Patients with TB on anti-TB therapy were included. Patients had a set of PET scans consisting of both (18) F-FDG and (68) Ga-citrate. Abnormal lesions were identified, and the two sets of scans were compared. The scan findings were correlated to the clinical data as provided by the attending physician. Results 46...
Alfred O. Ankrah, Ismaheel O. Lawal, Tebatso M. G. Boshomane, Hans C. Klein, Thomas Ebenhan, Rudi A. J. O. Dierckx, Mariza Vorster, Andor W. J. M. Glaudemans, Mike M. Sathekge
Frequency, Determinants, and Costs of Recommendations for Additional Imaging in Clinical F-18-FDG PET/CT Reports
Published in: Journal of Nuclear Medicine
Access to document
10.2967/jnumed.118.223362
document
Our purpose was to determine the frequency, determinants, and costs of recommendations for additional imaging (RAIs) in clinical F-18-FDG PET/CT reports. Methods: This retrospective study included a random sample of 2,643 F-18-FDG PET/CT scans that were performed for various clinical reasons at a tertiary-care academic medical center without financial incentives for self-referral, within a 1.5-y period. Results: Ninety-eight (3.7%) of 2,643 F-18-FDG PET/CT reports contained an RAI. None of the investigated variables (patient age, hospital status [inpatient or outpatient], indication for F-18-FDG PET/CT scanning [oncologic, infection/inflammation, or miscellaneous],...
Enhanced pulmonary uptake on 18F-FES-PET/CT scans after irradiation of the thoracic area: : related to fibrosis?
Published in: EJNMMI Research
Access to document
10.1186/s13550-019-0549-y
document
RATIONALE: The use of 16α-[18F]fluoro-17β-estradiol (FES) positron emission tomography (PET) in clinical dilemmas and for therapy decision-making in lesions expressing estrogen receptors is growing. However, on a considerable number of FES PET scans, previously performed in a research and clinical setting in our institution, FES uptake was noticed in the lungs without an oncologic substrate. We hypothesized that this uptake was related to pulmonary fibrosis as a result of radiation therapy. This descriptive study therefore aimed to investigate whether radiation therapy in the thoracic area is possibly related...
C M Venema, E F J de Vries, S J van der Veen, M D Dorrius, M van Kruchten, C P Schröder, G A P Hospers, A W J M Glaudemans